Navigation Links
DeCurtis Corporation Appoints Derek Fournier as CEO
Date:6/23/2020

DeCurtis Corporation, the premier provider of location and proximity enabled solutions in complex indoor environments, announced today that Derek Fournier has been appointed CEO and President. Founder and former CEO, David DeCurtis, will assume the role of Chairman of the Board, effective immediately.

“DeCurtis Corporation has been on an incredible journey for the last twenty years, and we have been fortunate to work with stellar clients on truly transformational solutions,” said David DeCurtis, Chairman of the Board at DeCurtis Corporation. “Derek has been with us since we first began focusing on cruise and indoor location services and has been a fundamental force in driving us to be the recognized leader in that space. His leadership as President for the past two years make it clear that he is the right choice to lead us into the future as we grow our presence in verticals including healthcare, education, commercial real estate and tourism.”

Mr. Fournier has been with DeCurtis Corporation for more than 10 years, and has served as President since 2018, during which he was responsible for business operations, sales and marketing functions. During his tenure as President, DeCurtis Corporation has created and gone to market with the premier architecture for location and proximity solutions serving complex indoor environments built atop the most advanced experience platform available on the market, the DeCurtis Experience Platform (DXP)™.

Under Mr. Fournier’s stewardship, DeCurtis recently launched DeCurtis Shield™, a combination of facial recognition and thermal imaging solutions to assess temperature movements of personnel. Unlike other temperature reading point-solutions in the marketplace, when tied to the DXP, DeCurtis Shield enables businesses to quickly deploy, assess, and create real-time and retroactive timelines to address potential outbreaks, identify interaction risks, as well as strategically plan for cleaning protocols.

“I am excited and honored to assume my role as CEO, particularly at such an important time in DeCurtis’ history,” said Mr. Fournier. “While the industries we serve face unique challenges, we are committed and well-equipped to utilize our industry-leading, tested and proven solutions to enable our clients and partners to open and operate their businesses safely. We have an amazing international team of compassionate and brilliant folks, and I look forward to continuing to collaborate with them to solve crucial pain-points for our clients across the many verticals in which we operate.”

About DeCurtis Corporation
DeCurtis Corporation is the premier provider of location and proximity enabled solutions in complex indoor environments with a focus on health, safety, and security, operational enhancement, and experience evolution. Creator of Mobile Assembly Suite (MAS™), the DeCurtis Experience Platform (DXP™), and DeCurtis Shield™, DeCurtis Corporation is the leader in providing transformational experience technology based on decades of deep industry knowledge in the cruise space that is applicable to other sectors. With a vast range of experience working with some of the world’s best, most-recognized brands, DeCurtis Corporation transforms the guest experience to be safer, secure and more efficient through the creative application of the latest technology. For more information on DeCurtis Corporation, please visit http://www.decurtis.com.

Press Contact:
Stephanie Casimiro, Director of Marketing
DeCurtis Corporation
Tel: (407) 965-1395
Direct: (386) 451-1194
Email: stephanie.casimiro@decurtis.com
Web: http://www.decurtis.com

Read the full story at https://www.prweb.com/releases/decurtis_corporation_appoints_derek_fournier_as_ceo/prweb17208147.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Agenda Released for Cognition Corporation’s User Conference
2. CNA Finance Initiates Research Coverage On Advanced Medical Isotope Corporation
3. United Therapeutics Corporation Reports Second Quarter 2017 Financial Results
4. From the Helm Webinar Series from Cognition Corporation
5. Exxact Corporation Enhances Its Deep Learning Portfolio with NVIDIA DGX Station and DGX-1
6. MSP Corporation Announces a New Breakthrough in Monodisperse Droplet Generation
7. China Cord Blood Corporation Receives Notification of Exercise of 7% Senior Convertible Notes
8. Japanese Corporation Selects Heidelberg Instruments' Advanced Gray Scale Lithography System
9. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017
10. VWR Corporation Reports Fourth Quarter 2016 Financial Results
11. Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses Encoding Reporter Genes From Genelux Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter maintenance and ... successful study, while protecting and accessing the catheter or device post-surgery is often undervalued ... Envigo in a live webinar on Wednesday, August 5, 2020 at ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... the early detection and prevention of high-burden diseases, and Centric Consulting, a business ... healthcare organizations to utilize existing data in order to identify and prioritize patients ...
(Date:7/10/2020)... ... 08, 2020 , ... Bode Technology, a leading ... operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical ... provides a turnkey solution that includes a comprehensive collection and virus-management program ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish embryos, ... PolyU research team led by Dr MA has been using the zebrafish model ...
Breaking Biology Technology:
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. today announced ... the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department ... scale-up a highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, ... need a comparability study, but what is the most effective way to complete ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in ... Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide ...
Breaking Biology News(10 mins):